首页> 外文会议>Latin American congress on biomedical engineering >Valor Clínico de la Medición del Gasto Cardiaco por Bioimpedancia
【24h】

Valor Clínico de la Medición del Gasto Cardiaco por Bioimpedancia

机译:生物阻抗测量心输出量的临床价值

获取原文

摘要

Hemodynamic monitoring is mandatory in critical care and a perioperative surgical patient, cardiac output is the most important hemodynamic functional parameter. Cardiac output invasive methods (thermo dilution) has been widely used it is very invasive highly risky and cannot be used in all patients its clinical usefulness has been challenged. Non invasive methods are more reliable to be used in all different clinical settings with acceptable accuracy and without risks. Bio-impedance cardiac output method has been widely used since 1969 when it was introduce by NASA its accuracy has been challenged nowadays technology advanced has allow this method to gain confidence and accuracy in many different clinical settings. Physio flow bioimpedance method was used in a 47 year old highly risk female with antecedent of mitral stenosis and low cardiac output syndrome submitted for partial hepa-tectomy. A pre induction cardiac output bioimpedance record confirms a low cardiac index with compensatory peripheral vaso-constriction. Bleeding and hypothermia was two of the major complications present after 4 hour surgery leading to a massive volume transfusion and atrial fibrillation. Cardiac output monitor-ing allows infusing large amounts of fluids when atrial fibrillation occurs there where not any significant drop on cardiac index ac-cording to bioimpedance monitoring allowing the anesthesiologist to treat with drugs instead or cardioversion. Bioimpedance was accurate method in this case allows to manage it safely with good perioperative results. Bioimpedance seems to be a useful cardiac output method for perioperative monitoring.
机译:在重症监护和围手术期患者中,必须进行血流动力学监测,心输出量是最重要的血流动力学功能参数。心脏输出侵入性方法(热稀释)已被广泛使用,具有很高的侵入性,且风险很高,不能在所有患者中使用,其临床实用性受到了挑战。非侵入性方法更可靠,可以在所有不同的临床环境中以可接受的精度使用,并且没有风险。自从美国宇航局(NASA)于1969年引入生物阻抗心输出量法以来,它的准确性就受到了挑战。如今,先进的技术使这种方法在许多不同的临床环境中获得了信心和准确性。生理流生物阻抗法用于47岁高风险女性,其二尖瓣狭窄和低心输出量综合征的患者需进行部分肝切除术。感应前的心输出量生物阻抗记录证实了低心脏指数和周围性代偿性血管收缩。出血和体温过低是导致4个小时手术后导致大量输血和心房颤动的两个主要并发症。当发生心房颤动时,通过心脏输出监测可以注入大量液体,而根据生物阻抗监测,心脏指数不会出现任何显着下降,从而使麻醉师可以替代药物或心脏复律进行治疗。在这种情况下,生物阻抗是一种准确的方法,可以安全地进行围手术期治疗,并具有良好的围手术期效果。生物阻抗似乎是围手术期监测的一种有用的心输出量方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号